Published by Frank Prenesti on 28th January 2025
(Sharecast News) - AstraZeneca and Daiichi Sankyo's Enhertu has been approved in the US for the treatment of adults with HER2 breast cancer, after disease progression having had one or more hormone therapies.
URL: http://www.digitallook.com/dl/news/story/34840605/...